GAMMA Investing’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.82K | Buy |
824
+603
| +273% | +$6.72K | ﹤0.01% | 3275 |
|
|
2026
Q1 | $2.44K | Sell |
221
-93
| -30% | -$1.44K | ﹤0.01% | 3601 |
|
|
2025
Q4 | $6.39K | Sell |
314
-47
| -13% | -$825 | ﹤0.01% | 3172 |
|
|
2025
Q3 | $5.71K | Sell |
361
-13
| -3% | -$192 | ﹤0.01% | 3123 |
|
|
2025
Q2 | $4.99K | Buy |
374
+137
| +58% | +$1.85K | ﹤0.01% | 3117 |
|
|
2025
Q1 | $2.42K | Buy |
237
+206
| +665% | +$2.39K | ﹤0.01% | 3357 |
|
|
2024
Q4 | $491 | Sell |
31
-36
| -54% | -$1.87K | ﹤0.01% | 3574 |
|
|
2024
Q3 | $3.89K | Buy |
67
+23
| +52% | +$1.14K | ﹤0.01% | 2846 |
|
|
2024
Q2 | $2.01K | Buy |
44
+2
| +5% | +$107 | ﹤0.01% | 2880 |
|
|
2024
Q1 | $2.78K | Buy |
42
+5
| +14% | +$296 | ﹤0.01% | 2637 |
|
|
2023
Q4 | $2.05K | Buy |
+37
| New | +$1.16K | ﹤0.01% | 2572 |
|
